OTTAVIANI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 2.278
EU - Europa 256
AS - Asia 138
OC - Oceania 3
SA - Sud America 3
Totale 2.678
Nazione #
US - Stati Uniti d'America 2.276
IT - Italia 75
SG - Singapore 71
IE - Irlanda 47
CN - Cina 38
RU - Federazione Russa 26
UA - Ucraina 20
DE - Germania 19
SE - Svezia 16
GB - Regno Unito 13
FR - Francia 9
NL - Olanda 9
ID - Indonesia 8
FI - Finlandia 7
BE - Belgio 5
IN - India 5
KR - Corea 5
AU - Australia 3
BR - Brasile 3
PH - Filippine 3
PL - Polonia 3
CA - Canada 2
GR - Grecia 2
IR - Iran 2
KG - Kirghizistan 2
NO - Norvegia 2
VN - Vietnam 2
AT - Austria 1
ES - Italia 1
HK - Hong Kong 1
LK - Sri Lanka 1
RO - Romania 1
Totale 2.678
Città #
Wilmington 682
Houston 660
Woodbridge 283
Fairfield 120
Chandler 75
Singapore 66
Ashburn 62
Dublin 40
Cambridge 39
New York 38
Seattle 38
Ann Arbor 36
Rome 32
Dearborn 23
Medford 21
Santa Clara 13
Lawrence 10
Beijing 8
Jakarta 7
Moscow 7
Boardman 6
Jacksonville 6
Brussels 5
Helsinki 5
Kilburn 5
Milan 5
Los Angeles 4
Menlo Park 4
Redwood City 4
Centrale 3
Creede 3
Jinan 3
London 3
Nanjing 3
San Diego 3
Shanghai 3
Dong Ket 2
Engelhard 2
Frankfurt am Main 2
Guangzhou 2
Hackensack 2
Hanover 2
Hull 2
Kendall Park 2
Lecce 2
Manila 2
Monte Vista 2
Mountain View 2
Munich 2
Norwalk 2
Nova Milanese 2
Nuremberg 2
Oslo 2
Pune 2
Renton 2
Rockdale 2
Roebling 2
San Francisco 2
Seoul 2
Sesto Fiorentino 2
Shenyang 2
São Paulo 2
Turin 2
Warsaw 2
Amsterdam 1
Ardabil 1
Ariccia 1
Baltimore 1
Bari 1
Billerica 1
Brisbane 1
Buffalo 1
Casalnuovo Di Napoli 1
Cerveteri 1
Changsha 1
Changzhi 1
Chapel Hill 1
Chengdu 1
Chicago 1
Chiswick 1
Chongqing 1
Cluj-napoca 1
Cornaredo 1
Denia 1
Groningen 1
Hounslow 1
Islington 1
Kaifeng 1
Kraków 1
Kunming 1
La Canada Flintridge 1
Latina 1
Nanchang 1
Phoenix 1
Pomezia 1
Prescot 1
Quezon City 1
Redmond 1
Rosmalen 1
Saint Petersburg 1
Totale 2.417
Nome #
Simulative and experimental characterization of a pH-dependent clamp-like DNA triple-helix nanoswitch 440
Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation 377
Entry, fate and degradation of DNA nanocages in mammalian cells: a matter of receptors 342
Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages 331
Engineering a responsive DNA triple helix into an octahedral DNA nanostructure for a reversible opening/closing switching mechanism: a computational and experimental integrated study 280
In vitro elimination of EGFR-overexpressing cancer cells by CD32A chimeric receptor T cells in combination with cetuximab or panitumumab 273
Real-time analysis of cleavage and religation activity of human topoisomerase 1 based on ternary fluorescence resonance energy transfer DNA substrate 170
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab 166
Imbibition of Femtoliter-Scale DNA-Rich Aqueous Droplets into Porous Nylon Substrates by Molecular Printing 164
In vitro and in silico characterization of an antimalarial compound with antitumor activity targeting human DNA topoisomerase IB 51
Topoisomerase IB: a relaxing enzyme for stressed DNA 46
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment 44
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B 26
Natural compounds as therapeutic agents: The case of human topoisomerase ib 25
EGFR+ Glioblastoma stem cells targeting by CD16158V-chimeric receptor T cells and cetuximab 23
Totale 2.758
Categoria #
all - tutte 7.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 0 103 97 94 93 84 72 62
2020/2021623 67 70 69 77 76 66 68 62 22 27 9 10
2021/2022131 4 6 4 10 3 13 8 12 5 27 9 30
2022/2023220 17 21 2 33 22 39 37 15 18 0 13 3
2023/2024155 15 9 13 4 21 51 8 6 5 2 1 20
2024/2025161 11 55 25 31 20 19 0 0 0 0 0 0
Totale 2.758